Pro Share Advisors LLC Kiniksa Pharmaceuticals, Ltd. Transaction History

Pro Share Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 10, 2022	SELL	$9.3 - $12.37 $103,629 - $137,838	-11,143 Closed	0 $0
Q4 2021 Feb 08, 2022	BUY	$10.39 - $15.15 $4,498 - $6,559	433 Added 4.04%	11,143 $131,000
Q3 2021 Nov 12, 2021	SELL	$11.39 - $16.23 $30,342 - $43,236	-2,664 Reduced 19.92%	10,710 $122,000
Q2 2021 Aug 13, 2021	BUY	$13.22 - $19.09 $23,981 - $34,629	1,814 Added 15.69%	13,374 $186,000
Q1 2021 May 14, 2021	BUY	$16.68 - $23.97 $12,576 - $18,073	754 Added 6.98%	11,560 $214,000
Q4 2020 Feb 09, 2021	BUY	$14.8 - $21.15 $159,928 - $228,546	10,806 New	10,806 $191,000

1.95M

Ticker KNSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,470,400
Market Cap $690M
Description
Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Pro Share Advisors LLC with notifications on news.